The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Ischaemic and bleeding outcomes in elderly patients undergoing a prolonged versus shortened duration of dual antiplatelet therapy after percutaneous coronary intervention: insights from the PRODIGY randomised trial

EuroIntervention 2017;13:78-86 published online January 2017. DOI: 10.4244/EIJ-D-16-00497

1. Bern University Hospital, University of Bern, Bern, Switzerland; 2. Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands; 3. Federico II University, Naples, Italy; 4. Division of Cardiology and Cardiovascular Pathophysiology, University of

Aims: The aim of this study was to evaluate the efficacy and safety of 24-month vs. six-month dual antiplatelet therapy (DAPT) among elderly (≥75 years) and non-elderly patients (<75 y

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Modified residual SYNTAX score and clinical outcomes in patients with multivessel disease undergoing percutaneous coronary intervention